Last reviewed · How we verify
NCT06334328
Virtual Reality-based Mindful Movement Therapy for Seniors
NA trial testing Virtual reality based mindful movement therapy in Cognitive Decline in 12 participants. Completed in 31 January 2024.
30 September 2023
Quick facts
| Lead sponsor | Drexel University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 12 |
| Start date | 15 August 2022 |
| Primary completion | 30 September 2023 |
| Estimated completion | 31 January 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Virtual reality based mindful movement therapy
Conditions studied
- Cognitive Decline — all drugs for Cognitive Decline →
- Physical Activity — all drugs for Physical Activity →
- Psychological Wellbeing — all drugs for Psychological Wellbeing →
Sponsor
Drexel University
Who can join
65 and older, any sex, with Cognitive Decline or Physical Activity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current proposal aims to 1) develop a technical platform and implementation plan for the delivery of a virtual reality-based mindful movement therapy (VR-MMT) protocol for older adults; and 2) conduct a clinical trial to examine the feasibility and preliminary efficacy of an 8-week, 16-session module VR-MMT intervention for this population. The findings of this study will help us to identify engagement barriers and refine the intervention contents as well as the study protocol necessary for the preparation of grant applications to conduct a controlled clinical trial. This study is innovative and high impact as this is the first study to examine the feasibility and preliminary efficacy of a VR-MMT intervention that could potentially ameliorate cognitive and mobility decline and promote psychological wellbeing in older adults by combining a widely accessible technology and creative embodiment-based approach.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06334328
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cognitive Decline
Currently open trials in the same condition.
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT07394504 — Effects of Turning Based Dual Task Training on Balance and Mild Cognitive Impairment in Diabetic Peripheral Neuropathy · NA · recruiting
- NCT07127965 — Exercise Adherence and Cognitive Decline: Phase 2 · NA · recruiting
- NCT07151365 — Plant-based Diets and Healthy Aging · recruiting
- NCT07399418 — TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics. · recruiting
Other Drexel University trials
Trials by the same sponsor.
- NCT07022808 — Tele-Exercise to Promote Empowered Movement in Individuals With Spinal Cord Injury · NA · not yet recruiting
- NCT07165522 — Centering Autistic Perspectives in Behavioral Intervention Discussions · NA · not yet recruiting
- NCT07225881 — Eatwell Clinical Trial (R01) · NA · recruiting
- NCT06690372 — Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming · NA · not yet recruiting
- NCT06972381 — Piloting a Patient Navigator Program for Weight Loss · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06334328 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Drexel University
- Last refreshed: 28 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06334328.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing